Source: Sleep and Breathing Conference 2021
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Voulgaris (Alexandroupolis, Greece), K. Archontogeorgis (Alexandroupolis, Greece), N. Paxinou (Alexandroupolis, Greece), E. Nena (Alexandroupolis, Greece), K. Bonelis (Alexandroupolis, Greece), P. Steiropoulos (Alexandroupolis, Greece). Serum levels of high sensitivity cardiac troponin and B-type natriuretic peptide in patients with COPD-OSA overlap syndrome. Sleep and Breathing Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 The incidence and significance of elevated B-type natriuretic peptide levels in patients hospitalized with apparent respiratory diseases Source: Eur Respir J 2004; 24: Suppl. 48, 279s Year: 2004 Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 The role of pro-brain natriuretic peptide and C-reactive protein as prognostic markers in stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020 Year: 2020 The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pleural effusions of cardiac origin Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism Source: Eur Respir J 2014; 43: 1669-1677 Year: 2014 New evidence of the effect of B-type natriuretic peptide (BNP) on human bronchi Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Effect of body mass index on B-type natriuretic peptide levels in critically ill patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Obstructive sleep apnoea does not cause elevated plasma levels of N-terminal pro-brain natriuretic peptide Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 The role of N-terminal pro B-type natriuretic peptide in predicting mortality of community acquired pneumonia Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis Year: 2019